vs
Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and Metropolitan Bank Holding Corp. (MCB). Click either name above to swap in a different company.
Metropolitan Bank Holding Corp. is the larger business by last-quarter revenue ($88.5M vs $71.1M, roughly 1.2× Fulgent Genetics, Inc.). On growth, Metropolitan Bank Holding Corp. posted the faster year-over-year revenue change (25.4% vs -3.2%). Over the past eight quarters, Metropolitan Bank Holding Corp.'s revenue compounded faster (14.3% CAGR vs 0.1%).
Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.
Sandy Spring Bancorp, Inc. was a bank holding company headquartered in Olney, Maryland and operating in the Washington metropolitan area. In addition to banking services, the company offered commercial and personal lines of insurance, surety bonds, workers compensation insurance, and professional liability insurance protection as well as financial planning, wealth management, and asset management for high-net-worth individuals, businesses, and associations. In April 2025, the company was acqu...
FLGT vs MCB — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $71.1M | $88.5M |
| Net Profit | — | $31.4M |
| Gross Margin | 30.2% | — |
| Operating Margin | 21.1% | — |
| Net Margin | — | 35.5% |
| Revenue YoY | -3.2% | 25.4% |
| Net Profit YoY | — | 92.2% |
| EPS (diluted) | $0.04 | $2.92 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $71.1M | $88.5M | ||
| Q4 25 | $83.3M | $88.4M | ||
| Q3 25 | $84.1M | $79.8M | ||
| Q2 25 | $81.8M | $76.3M | ||
| Q1 25 | $73.5M | $70.6M | ||
| Q4 24 | $76.2M | $71.0M | ||
| Q3 24 | $71.7M | $71.5M | ||
| Q2 24 | $71.0M | $67.7M |
| Q1 26 | — | $31.4M | ||
| Q4 25 | $-23.4M | $28.9M | ||
| Q3 25 | $-6.6M | $7.1M | ||
| Q2 25 | $-19.0M | $18.8M | ||
| Q1 25 | $-11.5M | $16.4M | ||
| Q4 24 | $-5.9M | $21.4M | ||
| Q3 24 | $-14.6M | $12.3M | ||
| Q2 24 | $-8.7M | $16.8M |
| Q1 26 | 30.2% | — | ||
| Q4 25 | 39.1% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | 42.1% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | 41.8% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 37.3% | — |
| Q1 26 | 21.1% | — | ||
| Q4 25 | -43.5% | 46.6% | ||
| Q3 25 | -18.3% | 12.8% | ||
| Q2 25 | -24.1% | 35.1% | ||
| Q1 25 | -26.9% | 33.1% | ||
| Q4 24 | -21.2% | 44.1% | ||
| Q3 24 | -23.8% | 24.6% | ||
| Q2 24 | -26.6% | 35.3% |
| Q1 26 | — | 35.5% | ||
| Q4 25 | -28.1% | 32.6% | ||
| Q3 25 | -7.9% | 8.9% | ||
| Q2 25 | -23.2% | 24.6% | ||
| Q1 25 | -15.7% | 23.2% | ||
| Q4 24 | -7.7% | 30.2% | ||
| Q3 24 | -20.4% | 17.2% | ||
| Q2 24 | -12.3% | 24.8% |
| Q1 26 | $0.04 | $2.92 | ||
| Q4 25 | — | $2.74 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $1.76 | ||
| Q1 25 | — | $1.45 | ||
| Q4 24 | — | $1.89 | ||
| Q3 24 | — | $1.08 | ||
| Q2 24 | — | $1.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.4M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $948.3M |
| Total Assets | $1.2B | $8.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $23.4M | — | ||
| Q4 25 | $50.2M | $393.6M | ||
| Q3 25 | $117.6M | $385.9M | ||
| Q2 25 | $87.9M | $152.5M | ||
| Q1 25 | $67.3M | $196.5M | ||
| Q4 24 | $55.1M | $200.3M | ||
| Q3 24 | $58.0M | $318.5M | ||
| Q2 24 | $65.1M | $244.7M |
| Q1 26 | — | $948.3M | ||
| Q4 25 | $1.1B | $743.1M | ||
| Q3 25 | $1.1B | $732.0M | ||
| Q2 25 | $1.1B | $723.0M | ||
| Q1 25 | $1.1B | $737.8M | ||
| Q4 24 | $1.1B | $729.8M | ||
| Q3 24 | $1.1B | $715.2M | ||
| Q2 24 | $1.1B | $692.4M |
| Q1 26 | $1.2B | $8.8B | ||
| Q4 25 | $1.2B | $8.3B | ||
| Q3 25 | $1.2B | $8.2B | ||
| Q2 25 | $1.2B | $7.9B | ||
| Q1 25 | $1.2B | $7.6B | ||
| Q4 24 | $1.2B | $7.3B | ||
| Q3 24 | $1.2B | $7.4B | ||
| Q2 24 | $1.2B | $7.3B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
